Baduanjin exercise program for chronic heart failure patients
Official title: Effect of an Exercise-based Cardiac Rehabilitation Program 'Baduanjin-eight-silken-movement With Self-efficacy Building' for Patients With Chronic Heart Failure in Guangzhou, China (BESMILE-HF Study)
Run by Guangdong Provincial Hospital of Traditional Chinese Medicine · NCT03180320 · Data updated 2026-11-12
This study tests whether a traditional Chinese exercise program can help people with chronic heart failure feel better and improve their overall health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Guangdong Provincial Hospital of Traditional Chinese Medicine Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | October 22, 2018 |
| Main results expected | December 31, 2025 |
| Study ends | June 30, 2026 |
| Registry record updated | May 18, 2025 |
| Trial ID | NCT03180320 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older diagnosed with chronic heart failure, specifically those in NYHA functional class II or III.
✕Probably not a fit
Patients with serious acute or chronic organic diseases, mental disorders, or those who cannot participate in exercise training may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This program integrates Baduanjin, a traditional Chinese exercise, into a cardiac rehabilitation framework for patients with chronic heart failure. It aims to provide a safe, low-cost, and equipment-free exercise option, along with education and support. The BESMILE-HF program will be evaluated through a randomized controlled trial and qualitative assessments to determine its efficacy and acceptability among patients in China. The study focuses on patients classified as NYHA Class II or III, who are clinically stable.
Why it matters
Potential benefit: If successful, this program could enhance the quality of life and physical function for patients with chronic heart failure.
How similar studies have gone: While the integration of traditional exercises like Baduanjin into cardiac rehabilitation is innovative, similar approaches have shown promise in other studies, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. aged 18 years or above 2. diagnosed with chronic heart failure 3. clinically stable as defined as symptoms and signs that have remained generally unchanged for at least 1 month 4. NYHA functional class II or III Exclusion Criteria: 1. patients who have contraindications to cardiopulmonary test 2. patients who have contraindications to exercise training 3. Patients who have serious acute or chronic organic disease or mental disorders 4. history of cardiac surgery, cardiac resynchronization therapy, or intracardiac defibrillation within the previous 3 months; 5. history of cardiac arrest within 1 year; 6. history of peripartum cardiomyopathy, hyperthyroid heart disease, primary pulmonary hypertension; 7. inability to perform a bicycle stress test; 8. severe cognitive dysfunction precluding informed consent or understanding of exercise concepts; 9. current regular Baduanjin or current participation in a conventional cardiac rehabilitation program 10. current participation in another trial.
Where it's running
-
Guangdong Provincial Hospital of Chinese Medicine
Guangzhou, Guangdong, China Recruiting
Study contacts
- Principal investigator: Weihui Lu — Guangdong Provincial Hospital of Traditional Chinese Medicine
- Study coordinator: Weihui Lu
- Email: weihui.lu@163.com
- Phone: +86(020)81887233
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SmartSignalHF remote monitoring for people with implanted ICD or CRT‑D and heart failure
This tests whether SmartSignalHF remote monitoring for people with implanted ICD or CRT‑D and chronic heart failure can reduce deaths and heart failure hospital visits over 12 months compared with standard remote monitoring.
-
Barostim therapy to help heart failure patients stay well
This study tests whether Barostim System-based baroreflex activation can reduce death and serious heart failure events in adults with moderate heart failure already on guideline-directed therapy.
-
Evaluating the Cordella Pulmonary Artery Sensor System for Heart Failure
This study is testing a new device that helps people with heart failure keep track of their heart health to see if it can improve their management of the condition.
-
Improving well-being and health in heart failure patients
This study is testing a new phone-based program that combines positive psychology and motivational support to see if it can help heart failure patients improve their health and well-being over six months.
-
Yoga-based cardiac rehabilitation for heart failure with reduced ejection fraction
This trial tests whether a yoga-based rehabilitation program can help people with heart failure and reduced ejection fraction compared with an educational program.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.